Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22166557 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
Condition: Hepatitis C, Chronic
Interventions: Drug: Copegus;   Drug: Pegasys;   Drug: RO4588161

Indicates status has not been verified in more than two years